Latest News

Antidepressant plus addiction medication are elements of new weight-loss drug

A new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval. The new prescription medication is a combination of two FDA-approved drugs, bupropion, an antidepressant and naltrexone, which reduces the desire for drugs and alcohol. Both have been found to increase weight-loss in independent research trials and the partnering of the two in one capsule is believed to create a synergistic effect.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Expensive TV ads missing their mark when people use smartphone or tablet too

  • Can a little loving kindness improve our mental health?

  • Glancing at greenery on a city rooftop can markedly boost concentration levels

  • Like Sleeping Beauty, some research lies dormant for decades, study finds

  • Attitudes about complementary and alternative medicine predict use among cancer patients

  • E-cigarette vapor, even when nicotine-free, found to damage lung cells

  • Cannabis use can be prevented, reduced or delayed

  • Research road map for brain-computer interfaces

  • Mutated gene leads to insensitivity to pain with drastic consequences

  • New insights could result in changes to the therapeutic strategy to combat Alzheimer's, reduce animal testing

  •